About Us

Current market trends establish a product need. Drug recalls have been steadily increasing since 2014. Products containing undeclared drug ingredients or particulate matter have been the most common reason for recalls since 2009.

InQuest Science Exclusivity

InQuest Science is the only digital defect management solution built by authors of USP 790 and 1790, the standards that govern pharmaceutical visual inspection. That expertise is embedded in the Identifier, which unites particulate and defect data across the entire product lifecycle, from raw materials to finished product, giving quality teams one source of truth in place of scattered spreadsheets and disconnected databases.

Purpose

InQuest Science LLC was established to develop and provide particulate matter, product defect trending and life cycle data management solutions for the Pharmaceutical, Medical Device and Health Care Industries.

Our Mission

Provide the Pharmaceutical, Medical Device, and Health Care Industries a modern electronic approach to process defect data management, and facilitate evaluation of each product batch before distribution to patients.

Distinction

The Identifier System is applicable to all pharma as well as CMOs, CROs, defect standards producers and particulate ID labs, transforming non-compliant spreadsheet storage into 21st century database management.

Why Choose Us

Specialized Expertise

Built by visual inspection experts for parenteral, ophthalmic, and medical device manufacturing.

One Source of Truth

All defect and particulate data in one 21 CFR Part 11 compliant system.

Faster, Compliant Workflows

Automates trending, control limits, and documentation once done by hand.

Training and Qualification

Manages defect test sets and tracks inspector and vision system qualification automatically.

Regulatory Confidence

Built by authors of USP 790 and 1790, including an active USP expert panel member.

Better Batch Decisions

Gives quality teams the full picture to confidently release or reject every batch.

Defect Library and Traceability

A master library of defect images and descriptions with full audit traceability.

Scales With You

Modular design fits any size producer and integrates with existing manufacturing and lab systems.

Our Team

  • Anthony Amato
    Chief Executive Officer

    Mr. Amato founded InQuest Science in March of 2017. He founded Amega Scientific Corporation in 1999. He grew the company from a startup operation to a worldwide industry leader.

  • Roy Cherris
    Chief Science Officer

    Mr. Cherris has over 40 years of Quality Assurance experience and is a founding member and Managing Partner of Bridge Associates International. An author of USP 790 and 1790 and an active member of the USP expert panel, he is one of the industry’s foremost authorities on visual inspection.

  • Jeff Marino
    Chief Technology Officer

    Mr Marino runs a successful software consultancy, BaSys Tech Services. He began his career in the pharmaceutical industry in 1993 building vision and barcode inspection systems.

  • Maggie Schwanda
    Director of Business Operations

    Ms. Schwanda was the Director of Business Operations for Amega Scientific Corporation. She was responsible for the groups global business development.

  • Anthony Amato II
    Product Development Manager

    Mr. Amato is responsible for the organization strategies through the effective direction and management of resources, while being accountable for the business strategies.

  • Scott Aldrich
    Scientific Advisor

    Mr. Aldrich worked in the pharmaceutical industry for over forty years and was an author of USP 790 and 1790. His expertise centered on the application of materials science methods for the identification of particulate matter.

  • Michael Winton
    Advisor

    Mr. Winton is a private equity professional and middle market CFO with more than 12 years of finance, investment banking, and corporate strategy experience.

Our Commitment

Behind every injectable drug is a patient who trusts it is safe. InQuest Science exists to help the companies who make those medicines honor that trust, giving quality teams a modern way to detect defects, qualify inspectors, and prove compliance with confidence. Our goal is simple: to set the new standard for particulate and defect data management, so that safer products reach the people who depend on them.